440 related articles for article (PubMed ID: 28771750)
41. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
43. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
[TBL] [Abstract][Full Text] [Related]
44. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
45. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
[TBL] [Abstract][Full Text] [Related]
46. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
47. Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients.
Baruah P; Lee M; Odutoye T; Williamson P; Hyde N; Kaski JC; Dumitriu IE
Immunobiology; 2012 Jul; 217(7):669-75. PubMed ID: 22204816
[TBL] [Abstract][Full Text] [Related]
48. Single-cell RNA sequencing reveals TCR
Jiang Y; Zhang S; Tang L; Li R; Zhai J; Luo S; Peng Y; Chen X; Wei L
Front Immunol; 2022; 13():1030222. PubMed ID: 36389736
[TBL] [Abstract][Full Text] [Related]
49. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
50. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL;
Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422
[TBL] [Abstract][Full Text] [Related]
51. Aligning digital CD8
Conde E; Caminoa A; Dominguez C; Calles A; Walter S; Angulo B; Sánchez E; Alonso M; Jimenez L; Madrigal L; Hernando F; Sanz-Ortega J; Jimenez B; Garrido P; Paz-Ares L; de Castro J; Hernandez S; Lopez-Rios F
Histopathology; 2018 Jan; 72(2):270-284. PubMed ID: 28815764
[TBL] [Abstract][Full Text] [Related]
52. HNSCC: Tumour Antigens and Their Targeting by Immunotherapy.
von Witzleben A; Wang C; Laban S; Savelyeva N; Ottensmeier CH
Cells; 2020 Sep; 9(9):. PubMed ID: 32942747
[TBL] [Abstract][Full Text] [Related]
53. Fewer tumour-specific PD-1
Xu K; Fu Y; Han Y; Xia R; Xu S; Duan S; Zhang Z; Li J
Br J Cancer; 2020 Sep; 123(6):932-941. PubMed ID: 32616847
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
55. Vaccination Expectations in HNSCC.
Syrjänen S; Rautava J
Recent Results Cancer Res; 2017; 206():257-267. PubMed ID: 27699546
[TBL] [Abstract][Full Text] [Related]
56. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
[TBL] [Abstract][Full Text] [Related]
57. The head and neck cancer immune landscape and its immunotherapeutic implications.
Mandal R; Şenbabaoğlu Y; Desrichard A; Havel JJ; Dalin MG; Riaz N; Lee KW; Ganly I; Hakimi AA; Chan TA; Morris LG
JCI Insight; 2016 Oct; 1(17):e89829. PubMed ID: 27777979
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Saloura V; Fatima A; Zewde M; Kiyotani K; Brisson R; Park JH; Ikeda Y; Vougiouklakis T; Bao R; Khattri A; Seiwert T; Cipriani N; Lingen M; Vokes E; Nakamura Y
Clin Cancer Res; 2017 Aug; 23(16):4897-4907. PubMed ID: 28442504
[No Abstract] [Full Text] [Related]
60. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
